Cost-effectiveness of first-v.second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy

Linda M. Davies*, Shôn Lewis, Peter B. Jones, Thomas R.E. Barnes, Fiona Gaughran, Karen Hayhurst, Alison Markwick, Helen Lloyd

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of first-v.second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Psychology